单剂氨甲环酸有效减少老年髋部骨折手术失血与输血率
这项单中心随机对照试验纳入老年髋部骨折手术患者,比较术前单剂15 mg/kg静脉氨甲环酸与安慰剂的效果。结果显示氨甲环酸组平均总失血量显著更低(902.4 ml vs 1226.3 ml,p=0.003),需要输注至少1单位红细胞的 likelihood 降低22%,股骨转子间骨折亚组差异更大。
要点
- 术前单剂15 mg/kg静脉氨甲环酸可显著降低老年髋部骨折手术总失血量。
- 氨甲环酸组需要输注至少1单位红细胞的 likelihood 降低22%。
- 股骨转子间骨折患者获益大于股骨颈骨折患者。
核心结论
- 老年股骨转子间骨折行髓内钉固定的患者,术前单剂15 mg/kg氨甲环酸可获益。
- 股骨颈骨折行半髋置换的患者呈现类似趋势,但未达统计学显著性。
研究设计与样本
- 单中心随机对照试验,氨甲环酸组77例(股骨颈骨折35例、转子间骨折42例),对照组88例(股骨颈骨折29例、转子间骨折59例)。
主要发现
- 氨甲环酸组平均总失血量为902.4 ml,对照组为1226.3 ml,差异有统计学意义(p=0.003)。
- 氨甲环酸组需要输注至少1单位红细胞的 likelihood 降低22%。
- 亚组分析显示股骨转子间骨折患者的上述差异大于股骨颈骨折患者。
关键数值与推荐
- 干预为术前切皮前单剂15 mg/kg静脉氨甲环酸稀释于100 ml生理盐水,或单剂100 ml生理盐水安慰剂。
- 主要结局为手术至术后第4天的总失血量和输血率。
临床怎么用
- 对老年股骨转子间骨折行髓内钉固定的患者,可考虑术前给予单剂15 mg/kg静脉氨甲环酸以减少失血和输血。
- 对股骨颈骨折行半髋置换的患者,氨甲环酸虽呈类似趋势但证据未达统计学显著,需个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to investigate the hypothesis that a single dose of tranexamic acid (TXA) would reduce blood loss and transfusion rates in elderly patients undergoing surgery for a subcapital or intertrochanteric (IT) fracture of the hip. METHODS: In this single-centre, randomized controlled trial, elderly patients undergoing surgery for a hip fracture, either hemiarthroplasty for a subcapital fracture or intramedullary nailing for an IT fracture, were screened for inclusion. Patients were randomly allocated to a study group using a sealed envelope. The TXA group consisted of 77 patients, (35 with a subcapital fracture and 42 with an IT fracture), and the control group consisted of 88 patients (29 with a subcapital fracture and 59 with an IT fracture). One dose of 15 mg/kg of intravenous (IV) TXA diluted in 100 ml normal saline (NS,) or one dose of IV placebo 100 ml NS were administered before the incision was made. The haemoglobin (Hb) concentration was measured before surgery and daily until the fourth postoperative day. The primary outcomes were the total blood loss and the rate of transfusion from the time of surgery to the fourth postoperative day. RESULTS: Homogeneity with respect to baseline characteristics was ensured between groups. The mean total blood loss was significantly lower in patients who received TXA (902.4 ml (-279.9 to 2,156.9) vs 1,226.3 ml (-269.7 to 3,429.7); p = 0.003), while the likelihood of requiring a transfusion of at least one unit of red blood cells was reduced by 22%. Subgroup analysis showed that these differences were larger in patients who had an IT fracture compared with those who had a subcapital fracture. CONCLUSION: Elderly patients who undergo intramedullary nailing for an IT fracture can benefit from a single dose of 15 mg/kg TXA before the onset of surgery. A similar tendency was identified in patients undergoing hemiarthroplasty for a subcapital fracture but not to a statistically significant level. Cite this article: Bone Joint J 2021;103-B(3):442-448.
引用
- Nikolaou VS, Masouros P, Floros T, et al. Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. Bone Joint J. 2021. PMID: 33641430. doi:10.1302/0301-620X.103B3.BJJ-2020-1288.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。